Thyroid Eye Disease: Incidence and Treatment

  Gary Joseph Lelli, MD, of the Department of Ophthalmology at Weill Cornell Medicine talks about the incidence and treatment options for thyroid eye disease due to Graves’ disease. Graves’ disease is an immune system disorder that results in the...

Getting Patient Groups, Researchers, and Industry to Share Data

  Femida Gwady-Sridhar, PhD, founder of Pulse Infoframe talks about the need for better collaboration between patient groups and researchers in regard to collecting and using data more effectively and efficiently. “For several years I did research in cardiology...

An Oral Film to Treat Lennox-Gastaut Disease

  Daniel Barber is chief operating officer at Aquestive Therapeutics, a specialty pharmacy company that is highly focused on providing treatment options for persons unable to properly swallow medicine (e.g., people with epilepsy, ALS, Parkinson’s, etc). Recently,...

FDA Reviewing Drug Application for Neuromyelitis Optica

The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Biologics License Application (BLA) for satralizumab to treat adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD). The FDA’s review will largely focus on two Phase III studies...

Gene Therapy for ADA-SCID

  Bobby Gasper, MD Chief Scientific Officer of Orchard Therapeutics talks about his company’s gene therapy in development to treat children with adenosine deaminase severe combined immunodeficiency (ADA-SCID). “These children are born without functional...
  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.